Mr. Goldberg has served as a director since March 2011. He is a Vice President at Clal Biotechnology Industries (TASE: CBI), leading CBI’s strategic investment decisions and technological development. Mr. Goldberg is also the managing director of Anatomy Medical Technology fund, CBI’s medical device investment arm. Mr. Goldberg serves as executive chairman and board member of several biomedical companies. He holds an M.A. in Economics and Finance from Tel Aviv University and a B.Sc. in Physics and Mathematics from the Hebrew University of Jerusalem.